Coffee and acute ischemic stroke onset
The Stroke Onset Study
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: Prior research suggests an acutely elevated risk of myocardial infarction and sudden cardiac death in the hour after coffee intake. However, the risk of ischemic stroke associated with transient exposure to coffee remains unclear. We hypothesized that caffeine intake is associated with a transiently increased risk of ischemic stroke.
Methods: In this multicenter case-crossover study, we interviewed 390 subjects (209 men, 181 women) between January 2001 and November 2006 a median of 3 days after acute ischemic stroke. Each subject's coffee consumption in the hour before stroke symptoms was compared with his or her usual frequency of consumption in the prior year.
Results: Of the 390 subjects, 304 (78%) drank coffee in the prior year, 232 within 24 hours and 35 within 1 hour of stroke onset. The relative risk (RR) of stroke in the hour after consuming coffee was 2.0 (95% confidence interval [CI], 1.4–2.8; p < 0.001). There was no apparent increase in risk in the hour following consumption of caffeinated tea (RR = 0.9, 95% CI 0.4–2.0; p = 0.85) or cola (RR = 1.0, 95% CI 0.4–2.4; p = 0.95). The association between ischemic stroke in the hour after coffee consumption was only apparent among those consuming ≤1 cup per day but not for patients who consumed coffee more regularly (p for trend = 0.002). Relative risks remained similar when the sample was restricted to those who were not simultaneously exposed to other potential triggers and the results remained significant after stratifying by time of day.
Conclusion: Coffee consumption transiently increases the risk of ischemic stroke onset, particularly among infrequent drinkers.
Footnotes
-
Study funding: Supported by the American Heart Association (0140219N to M.A.M.) and the NIH/NIAID (T32-A1007535-11 to E.M.).
-
- CI
- confidence interval
- MI
- myocardial infarction
- RR
- relative risk
- TOAST
- Trial of Org 10172 in Acute Stroke Treatment
-
Editorial, page 1576
- Received February 17, 2010.
- Accepted June 1, 2010.
- Copyright © 2010 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Coffee and acute ischemic stroke onset: The Stroke Onset Study
- Matthew R. Walters, Professor of Clinical Pharmacology, University of Glasgowmatthew.walters@glasgow.ac.uk
- Andrew Haslett, Jesse Dawson
Submitted May 25, 2011 - Coffee and acute ischemic stroke onset: The Stroke Onset Study
- Adnan I. Qureshi, Professor, University of Minnesotaqureshi@umn.edu
- Donald L. Bliwise, PhD
Submitted May 25, 2011 - Reply from the authors
- Murray A. Mittleman, Director, Cardiovascular Epidemiology Research Unit, Department of Medicine, Beth Israel Deaconess Medical Centermmittlem@bidmc.harvard.edu
- Elizabeth Mostofsky
Submitted May 25, 2011
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Editorials
Ischemic strokeCoffee may pull the triggerGiancarlo Logroscino, Tobias Kurth et al.Neurology, September 29, 2010 -
Articles
Caffeine, postmenopausal estrogen, and risk of Parkinson’s diseaseA. Ascherio, H. Chen, M.A. Schwarzschild et al.Neurology, March 11, 2003 -
Articles
The neuroprotective effects of caffeineA prospective population study (the Three City Study)K. Ritchie, I. Carrière, A. de Mendonça et al.Neurology, August 06, 2007 -
Articles
Caffeinated clues from epidemiology of Parkinson’s diseaseAlberto Ascherio, Honglei Chen et al.Neurology, December 08, 2003